Codexis Partners with Innovatus for a $40 Million Loan to Revolutionize RNAi Therapeutic Production
In a strategic finance maneuver, Codexis, Inc., a leader in enzyme engineering and NASDAQ-listed innovator, has inked a term loan agreement with Innovatus Capital Partners, LLC, securing up to $40 million. This partnership marks a significant milestone, channeling funds into Codexis's ambitious project – the development of their proprietary ECO Synthesis™ platform for RNAi therapeutics.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
